Abstract
No public abstract is available from the verified source records.
Iris Lavon, Alexander Lossos, Nima Sharifi, Justin D. Lathia
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Androgen loss accelerates brain tumour growth via HPA axis activation
10.1038/s41586-026-10451-5 · 2026
Androgen receptor: a potential therapeutic target for glioblastoma
10.18632/oncotarget.25007 · 2018
Androgen receptor activation in glioblastoma can be achieved by ligand-independent signaling through EGFR—a potential therapeutic target
10.3390/ijms222010954 · 2021
Intracranial assessment of androgen receptor antagonists in mice bearing human glioblastoma implants
10.3390/ijms25010332 · 2023
Expression of the androgen receptor governs radiation resistance in a subset of glioblastomas vulnerable to antiandrogen therapy
10.1158/1535-7163.mct-20-0095 · 2020
Small-molecule HSP27 inhibitor abolishes androgen receptors in glioblastoma
10.1021/acs.jmedchem.0c01537 · 2021
Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure
10.1016/j.annonc.2019.12.002 · 2020
Females have the survival advantage in glioblastoma
10.1093/neuonc/noy002 · 2018
Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1038/s41591-019-0566-4 · 2019
P06.04.A first in human - targeting androgen receptor for glioblastoma therapy
10.1093/neuonc/noae144.141 · 2024
No additional external references are available.